Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Ribosomal protein S6 kinase alpha-3 | ||
Ligand | BDBM50021659 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1368328 (CHEMBL868674) | ||
IC50 | 6300±n/a nM | ||
Citation | Costales, A; Mathur, M; Ramurthy, S; Lan, J; Subramanian, S; Jain, R; Atallah, G; Setti, L; Lindvall, M; Appleton, BA; Ornelas, E; Feucht, P; Warne, B; Doyle, L; Basham, SE; Aronchik, I; Jefferson, AB; Shafer, CM 2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitors. Bioorg Med Chem Lett24:1592-6 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Ribosomal protein S6 kinase alpha-3 | |||
Name: | Ribosomal protein S6 kinase alpha-3 | ||
Synonyms: | 90 kDa ribosomal protein S6 kinase 3 | ISPK-1 | ISPK1 | KS6A3_HUMAN | MAP kinase-activated protein kinase 1b | MAPKAPK1B | RPS6KA3 | RPS6KA3(Kin.Dom.1 - N-terminal) | RSK2 | Ribosomal S6 kinase 2 (RSK2) | Ribosomal protein S6 kinase | Ribosomal protein S6 kinase alpha-1/alpha-3 | Ribosomal protein S6 kinase alpha-3 (RSK2) | Ribosomal protein S6 kinase alpha-3 (RSK3) | S6K-alpha 3 | insulin-stimulated protein kinase 1 | p90 ribosomal s6 kinase (RSK2) | p90-RSK 3 | p90RSK | pp90RSK2 | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 83740.03 | ||
Organism: | Homo sapiens (Human) | ||
Description: | The human RSK2 sequence differed from the Genbank entry NM_004586 at one residue, V45G. The protein was cloned and purified from baculovirus expression system. | ||
Residue: | 740 | ||
Sequence: |
| ||
BDBM50021659 | |||
n/a | |||
Name | BDBM50021659 | ||
Synonyms: | CHEMBL3297951 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H24FN3O4 | ||
Mol. Mass. | 449.4742 | ||
SMILES | COc1ccc(Nc2nc3cccc(-c4c(F)cccc4OC)c3o2)cc1O[C@H]1CCNC1 |r,wU:28.31,(10.88,-23.43,;12.42,-23.43,;13.19,-22.09,;12.42,-20.76,;13.19,-19.42,;14.73,-19.43,;15.5,-18.1,;17.04,-18.1,;17.95,-16.86,;19.41,-17.33,;20.74,-16.56,;22.07,-17.32,;22.08,-18.87,;20.74,-19.65,;20.75,-21.19,;19.42,-21.96,;18.08,-21.18,;19.42,-23.49,;20.75,-24.27,;22.09,-23.49,;22.08,-21.95,;23.41,-21.18,;24.75,-21.94,;19.41,-18.87,;17.94,-19.35,;15.5,-20.76,;14.73,-22.09,;15.51,-23.42,;14.74,-24.76,;15.37,-26.16,;14.23,-27.2,;12.89,-26.43,;13.21,-24.92,)| | ||
Structure |